Evidence map›Paper›PMID 29321030›Full record

ArticleBMC cancer2018

CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension.

Ricardo Celestino, Torfinn Nome, Ana Pestana, Andreas M Hoff, A Pedro Gonçalves, Luísa Pereira, Bruno Cavadas, Catarina Eloy, Trine Bjøro, Manuel Sobrinho-Simões and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Lipocalin-2 expression in papillary thyroid carcinoma and its association with clinicopathological characteristics.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  7. NF-κB in Thyroid Cancer: An Update.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Biochemistry and biophysics reports · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Ricardo Celestinoi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.
Torfinn NomeDepartment of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, P.O.Box 4953 Nydalen, 0424, Oslo, Norway.
Ana Pestanai3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.
Andreas M HoffDepartment of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, P.O.Box 4953 Nydalen, 0424, Oslo, Norway.
A Pedro Gonçalvesi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.
Luísa Pereirai3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.
Bruno Cavadasi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.
Catarina Eloyi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.
Trine BjøroDepartment of Medical Biochemistry, Norwegian Radium Hospital, Oslo University Hospital, 0424, Oslo, Norway.
Manuel Sobrinho-Simõesi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.
Rolf I SkotheimDepartment of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, P.O.Box 4953 Nydalen, 0424, Oslo, Norway. Rolf.I.Skotheim@rr-research.no.
Paula Soaresi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal. psoares@ipatimup.pt.
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PTOslo University Hospital · NOInstitute of Biomedical Science · GBUniversidade do Porto · PTUniversity of Oslo · NO

Funding

Fundo Regional para a Ciência e Tecnologia NORTE-01-0145-FEDER-000029Fundo Regional para a Ciência e Tecnologia POCI-01-0145-FEDER-007274Norges Forskningsråd (NO) 179571
6 · The paper itself

Abstract

backgroundThe prognostic variability of thyroid carcinomas has led to the search for accurate biomarkers at the molecular level. Follicular thyroid carcinoma (FTC) is a typical example of differentiated thyroid carcinomas (DTC) in which challenges are faced in the differential diagnosis.

methodsWe used high-throughput paired-end RNA sequencing technology to study four cases of FTC with different degree of capsular invasion: two minimally invasive (mFTC) and two widely invasive FTC (wFTC). We searched by genes differentially expressed between mFTC and wFTC, in an attempt to find biomarkers of thyroid cancer diagnosis and/or progression. Selected biomarkers were validated by real-time quantitative PCR in 137 frozen thyroid samples and in an independent dataset (TCGA), evaluating the diagnostic and the prognostic performance of the candidate biomarkers.

resultsWe identified 17 genes significantly differentially expressed between mFTC and wFTC. C1QL1, LCN2, CRABP1 and CILP were differentially expressed in DTC in comparison with normal thyroid tissues. LCN2 and CRABP1 were also differentially expressed in DTC when compared with follicular thyroid adenoma. Additionally, overexpression of LCN2 and C1QL1 were found to be independent predictors of extrathyroidal extension in DTC.

conclusionsWe conclude that the underexpression of CRABP1 and the overexpression of LCN2 may be useful diagnostic biomarkers in thyroid tumours with questionable malignity, and the overexpression of LCN2 and C1QL1 may be useful for prognostic purposes.

Indexed as

Adenocarcinoma, FollicularAgedAged, 80 and overBiomarkers, TumorComplement C1qDiagnosis, DifferentialExtracellular Matrix ProteinsFemaleGene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingHumansLipocalin-2MaleMiddle AgedNeoplasm InvasivenessPrognosisBiomarkers, TumorC1QL1 protein, humanCILP protein, humanComplement C1qExtracellular Matrix ProteinsLCN2 protein, humanLipocalin-2PyrophosphatasesReceptors, Retinoic Acidretinoic acid binding protein I, cellularBiomarkerC1QL1CancerCILPCRABP1Gene expressionLCN2RNA sequencingTCGAThyroid

Identifiers

PMID29321030
PMCPMC5763897
OpenAlexW2783271777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.